All Articles

Amid ongoing drug shortages, Phlow Corp. is advocating for a stronger domestic pharmaceutical supply chain. CEO Dr. Eric Edwards testified before Congress, highlighting the need for resilience and innovation in American medicine.

Octopus AIM VCT 2 plc has completed a share buyback, reducing its issued share capital. Analysts examine the move's implications for investors and the broader VCT landscape, assessing financial health & future prospects.

A preliminary valuation of Oncotelic Therapeutics’ joint venture pipeline has reached $1.7 billion, spotlighting the potential of targeted nanomedicine and the growing appetite for innovative biotech assets in Hong Kong.

New report reveals 97% of organizations impacted by supply chain breaches, despite increased investment in security. Is the focus on compliance eclipsing genuine risk reduction?

As electric vehicles and energy storage surge, a new fire suppression technology is being evaluated in Honolulu. Will this water-based agent prove effective against increasingly dangerous battery fires?

The convenient nutrition company authorizes a $600M share repurchase program, signaling confidence despite lowered growth forecasts and increased competition. A deeper look at the strategy and what it means for investors.

A strategic alliance aims to restore investor confidence in Panama's citizenship-by-investment program, boosting tourism and real estate development in the Central American nation.

Minovia Therapeutics is set to present encouraging clinical and pre-clinical data for its mitochondrial augmentation technology at ASH. The company is also pursuing a listing on Nasdaq through a merger with LaunchOne Acquisition Corp, potentially unlocking a new era of treatment for Myelodysplastic Syndromes.

As enterprises increasingly adopt decentralized technologies, a critical security gap emerges. Checkmarx and CredShields are joining forces to offer a comprehensive AppSec solution for the rapidly evolving Web3 landscape.

Texas-based Cipher Mining secures $333M to expand its data center footprint, betting on HPC demand despite cryptocurrency market uncertainties. A deep dive into the company's strategy and its impact on the infrastructure landscape.

The acquisition signals a growing trend toward AI-enhanced internal platforms, with uStudio poised to deliver intelligent audio and video experiences for a more engaged workforce.

ENDRA Life Sciences’ thermoacoustic imaging technology aims to disrupt the liver disease diagnostics market with a cost-effective, accessible alternative to MRI. But can this financially challenged medtech firm deliver on its promise?

The energy conversion and control systems leader is boosting its share repurchase program to $1.8 billion, underscoring strong financial health and a commitment to delivering value to shareholders amid a dynamic market.

A new UNICEF report reveals Canada's declining performance in child welfare, prompting youth advocates to urge Ottawa for a national strategy addressing poverty, healthcare, and climate change.

Bayer’s sevabertinib receives accelerated FDA approval for HER2-mutated NSCLC, offering new hope for a previously underserved patient population. Experts discuss the drug's potential and the evolving landscape of targeted cancer therapies.

A new executive program blends academic rigor with real-world insights from Manchester City, aiming to train the next generation of sports business leaders for an increasingly globalized industry.

New Delhi summit signals a shift for India's pharmaceutical industry, emphasizing partnerships, R&D, and a move beyond generics to become a global 'Pharma Powerhouse' by 2047.

Controlled environment agriculture company expands retail footprint in Northeast, riding consumer demand for fresh, locally-sourced food while navigating a challenging financial landscape.

Florida’s housing market is cooling, but LGI Homes is doubling down on affordability with Fulton Meadows, a new single-family community in Lakeland. Can the builder’s ‘CompleteHome’ package navigate changing buyer preferences and economic headwinds?

A new biotechnology-based mouth spray, Murnia®, is entering the market, offering a unique solution for persistent oral dryness by focusing on natural hydration without stimulating saliva – a shift from traditional remedies.